COMPARISON OF COSTS ASSOCIATED WITH TURP AND PROSTATIC URETHRAL LIFT FOR BENIGN PROSTATIC HYPERPLASIA

被引:3
|
作者
Orlowski, A. [1 ]
Kayes, O. [2 ]
机构
[1] Imperial Coll Hlth Partners, London, England
[2] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England
关键词
D O I
10.1016/j.jval.2018.04.1811
中图分类号
F [经济];
学科分类号
02 ;
摘要
PUK20
引用
收藏
页码:S268 / S268
页数:1
相关论文
共 50 条
  • [41] Benign Prostatic Hyperplasia Is bipolar TURP superior than monopolar?
    Leyh, Herbert
    AKTUELLE UROLOGIE, 2016, 47 (02) : 116 - 117
  • [42] Preservation of Sexual Function with the Prostatic Urethral Lift: A Novel Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
    Woo, Henry H.
    Bolton, Damien M.
    Laborde, Eric
    Jack, Greg
    Chin, Peter T.
    Rashid, Prem
    Thavaseelan, Jeffrey
    McVary, Kevin T.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 (02): : 568 - 575
  • [43] Multicentre prospective crossover study of the 'prostatic urethral lift' for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Cantwell, Anthony L.
    Bogache, William K.
    Richardson, Steven F.
    Tutrone, Ronald F.
    Barkin, Jack
    Fagelson, James E.
    Chin, Peter T.
    Woo, Henry H.
    BJU INTERNATIONAL, 2014, 113 (04) : 615 - 622
  • [44] A cost-effectiveness analysis of pharmacotherapy versus prostatic urethral lift as initial therapy for patients with moderate benign prostatic hyperplasia
    Tung, Joshua Y. M.
    Aslim, Edwin J.
    Ho, Henry S. S.
    Chen, Cynthia
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (01) : 63 - 68
  • [45] TRENDS IN MINIMALLY INVASIVE SURGICAL THERAPIES FOR BENIGN PROSTATIC HYPERPLASIA: TREATMENT SUBSTITUTION OR TREATMENT EXPANSION EFFECT BY PROSTATIC URETHRAL LIFT?
    Dalimov, Zafardjan
    Hamann, Harold
    Alavi-Dunn, Nicole
    Ernst, Michael
    Chevli, Kent
    JOURNAL OF UROLOGY, 2020, 203 : E621 - E622
  • [46] COST-EFFECTIVENESS OF CONVECTIVE WATER VAPOR ENERGY THERAPY COMPARED TO PROSTATIC URETHRAL LIFT FOR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
    Neeser, K.
    Chughtai, B.
    Rojanasarot, S.
    Amorosi, S. L.
    Appah-Gyamenah, V
    Gultyaev, D.
    Minshall, M.
    Shore, N. D.
    VALUE IN HEALTH, 2019, 22 : S915 - S915
  • [47] Comparative efficacy and safety of prostatic urethral lift vs prostatic artery embolization for benign prostatic hyperplasia: a systematic review and network meta-analysis
    Lucas-Cava, Vanesa
    Miguel Sanchez-Margallo, Francisco
    Insausti-Gorbea, Inigo
    Sun, Fei
    BJU INTERNATIONAL, 2023, 131 (02) : 139 - 152
  • [48] TRANS-URETHRAL ENUCLEATION OF BENIGN PROSTATIC HYPERPLASIA
    HIRAOKA, Y
    AKIMOTO, M
    JOURNAL OF UROLOGY, 1989, 142 (05): : 1247 - 1250
  • [49] BENIGN PROSTATIC HYPERPLASIA - ASSOCIATED PATHOLOGY
    USAI, E
    SCARPA, RM
    DELISA, A
    PORRU, D
    JOURNAL D UROLOGIE, 1995, 101 (01) : 53 - 54
  • [50] Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia
    Popovics, Petra
    Awadallah, Wisam N.
    Kohrt, Sarah E.
    Case, Thomas C.
    Miller, Nicole L.
    Ricke, Emily A.
    Huang, Wei
    Ramirez-Solano, Marisol
    Liu, Qi
    Vezina, Chad M.
    Matusik, Robert J.
    Ricke, William A.
    Grabowska, Magdalena M.
    PROSTATE, 2020, 80 (10): : 731 - 741